Fp. Chen et al., THE USE OF SERUM CA-125 AS A MARKER FOR ENDOMETRIOSIS IN PATIENTS WITH DYSMENORRHEA FOR MONITORING THERAPY AND FOR RECURRENCE OF ENDOMETRIOSIS, Acta obstetricia et gynecologica Scandinavica, 77(6), 1998, pp. 665-670
Background. To estimate the value of CA-125 for the diagnosis of endom
etriosis in women with dysmenorrhea, as well as its significance in mo
nitoring therapy and follow-up. Methods. One hundred and fifty-seven w
omen undergoing laparoscopy for dysmenorrhea were prospectively studie
d for serum CA-125 concentration. For those with advanced endometriosi
s receiving danazol treatment after conservative surgery, CA-125 was a
lso determined every month during medication and once every 12 months
after treatment. Results. The sensitivity and specificity of serum CA-
125 for the diagnosis of endometriosis were 61.1% and 87.5% respective
ly. Elevated CA-125 (>35 U/ml) was noted in 65/75 cases (86.7%) with a
dvanced endometriosis, but in only 15/56 patients (26.8%) with minimal
and mild endometriosis. Although there were significantly higher CA-1
25 levels in unmarried women, and a negative correlation (r=-0.1970, p
=0.0284) between CA-125 and parity, there was no statistical differenc
e in incidence of endometriosis by the status of marriage or parity. T
en women with advanced endometriosis were found with persistent endome
triosis by laparoscopy during danazol treatment, even though they test
ed with normal CA-125 levels (<35 U/ml) at that time. Fifteen patients
had elevated CA-125 levels before and one year after therapy, and wer
e confirmed with recurrence of endometriosis by laparoscopy. Nine wome
n with elevated CA-125 levels before treatment, were found without rec
urrence of endometriosis and had normal CA-125 levels one year after t
herapy. Conclusion. For endometriosis, CA-125 is a valuable adjuvant i
n the follow-up of recurrence in patients with advanced endometriosis
and initially elevated CA-125 levels. It is not an effective screening
tool for patients with dysmenorrhea, or for monitoring therapy. There
was no significant correlation between the development of endometrios
is and reproductive factors.